Aravive, Inc., a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced that in accordance with Nasdaq rules regarding employment inducement awards, the Company has granted an equity compensation award to a new employee.
June 13, 2023
· 4 min read